EUCTR2012-000775-17-ES进行中(未招募)不适用
A comparative, randomised controlled trial for evaluating the efficacy of dexamethasone administration in the treatment of patients with the Acute Respiratory Distress Syndrome
Jesús Villar Hernández0 个研究点开始时间: 2012年7月19日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •To be eligible for inclusion into this study (Day 0), each patient must fulfil the following inclusion criteria during screening and prior to the enrolment into the study:
- •a.Age >=18 years old
- •b.Patients must have acute onset of ARDS, as defined by the American-European Consensus Conference (AECC) criteria for ARDS:
- •i.Having an initiating clinical condition (pneumonia, aspiration, inhalation injury, sepsis, trauma, acute pancreatitis, etc.).
- •ii.bilateral infiltrates on frontal chest radiograph
- •iii.absence of left atrial hypertension, a pulmonary capillary wedge pressure (PCWP) less than 18 mm Hg, or no clinical signs of left heart failure
- •iv.severe hypoxemia (a PaO2/FIO2 <=200 mm Hg, regardless of FIO2 or positive end-expiratory pressure (PEEP)
- •c.Be intubated and mechanically ventilated
- •d.Have provided signed written informed consent from the patient or the patient's personal legal representative.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 264
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 50
排除标准
- •To be eligible for inclusion into this study (Day 0), each patient must not have any of the following exclusion criteria during screening and prior to the enrolment into the study:
- •e.Be a woman known to be pregnant or lactating
- •f.Take part in another experimental treatment protocol (simultaneously)
- •g.Brain death
- •h.Terminal-stage cancer or other terminal disease
- •i.Having do-not-resuscitate orders
- •j.Being immune-compromised
- •k.Receiving corticosteroids or immunosuppressive drugs
- •l.Patients in whom more than 24 hours had elapsed after initially meeting the AECC ARDS criteria before consent and results of initial standard ventilator settings could be obtained.
- •m.Have severe chronic obstructive pulmonary disease (COPD)
- •n.Have congestive heart failure
研究者
相似试验
招募中
4 期
Efficacy of DEXamethasone in Patients With Acute Hypoxemic REspiratory Failure Caused by INfEctions (DEXA-REFINE)2024-519759-27-00Consorcio Centro De Investigacion Biomedica En Red980
已完成
3 期
A randomized, open-label, comparative trial to evaluate the effects on ovarian function of a monophasic combined oral contraceptive (COC) containing 2.5 mg nomegestrol acetate (NOMAC) and 1.5 mg estradiol (E2), compared to a monophasic COC containing 3 mg drospirenone (DRSP) and 30 µg ethinyl estradiol (EE).NL-OMON29993Organon Nederland BV48
进行中(未招募)
1 期
A randomized, open-label, comparative trial to evaluate the effects on ovarian function of a monophasic combined oral contraceptive (COC) containing 2.5 mg nomegestrol acetate (NOMAC) and 1.5 mg estradiol (E2), compared to a monophasic COC containing 3 mg drospirenone (DRSP) and 30 µg ethinyl estradiol (EE).EUCTR2006-001546-14-NLV Organon48
尚未招募
2 期
Comparison of effect of Darvyadi ghee verses Darvyadi kwath in two group w.s.r.DMCTRI/2019/04/018366All India Institute of Ayurveda
尚未招募
3 期
A study to evaluate the efficacy and safety of Shuddhi Vati in comparision with Lactulose in children suffering from chronic constipatioCTRI/2020/06/026163ational Institute Of Medical Sciences Research Jaipur
